| P2093 | author name string | John MacKenzie | |
| | Xiaojuan Li | |
| | Randall A Hawkins | |
| | Benjamin L Franc | |
| | Salma Jivan | |
| | Henry VanBrocklin | |
| | Joseph Blecha | |
| | Sam Goth | |
| | Tina Lam | |
| P2860 | cites work | Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non-coding RNAs in T cells | Q39018269 |
| | Foxp3, Regulatory T Cell, and Autoimmune Diseases | Q39018591 |
| | Synthesis of 2′-Deoxy-2′-[18F]Fluoro-9-β-D-Arabinofuranosylguanine: a Novel Agent for Imaging T-Cell Activation with PET | Q39656230 |
| | Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists | Q40561067 |
| | Deficient Activity of the Nuclease MRE11A Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis. | Q42363315 |
| | Multimodality imaging of T-cell hybridoma trafficking in collagen-induced arthritic mice: image-based estimation of the number of cells accumulating in mouse paws. | Q45874064 |
| | A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant | Q46121892 |
| | Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models. | Q48483233 |
| | Expression of soluble programmed death-1 protein in peripheral blood regulatory T cells and its effects on rheumatoid arthritis progression | Q50193751 |
| | The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis | Q57232112 |
| | Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation | Q72989725 |
| | Regulation of TCR-mediated T cell activation by TNF-RII | Q73910634 |
| | Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig | Q79290408 |
| | Defective T-cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency | Q81159478 |
| | Chronic TNF-alpha exposure impairs TCR-signaling via TNF-RII but not TNF-RI | Q81568739 |
| | ??? | Q28080246 |
| | Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside | Q26764858 |
| | The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis | Q26766297 |
| | HTLV-1, Immune Response and Autoimmunity | Q26771801 |
| | T Cell Migration in Rheumatoid Arthritis | Q26797338 |
| | Anti-TNF therapy: past, present and future | Q26997311 |
| | High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers | Q27300777 |
| | IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity | Q28069295 |
| | Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors. | Q30828860 |
| | CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses | Q33591684 |
| | Modes of action of Freund's adjuvants in experimental models of autoimmune diseases | Q34460923 |
| | Synovial IL-21/TNF-producing CD4+ T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes | Q34542454 |
| | Qualitative differences between naïve and memory T cells | Q34669540 |
| | Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis | Q35157400 |
| | Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis | Q36673061 |
| | Imaging of carrageenan-induced local inflammation and adjuvant-induced systemic arthritis with [(11)C]PBR28 PET | Q37210950 |
| | T cells in rheumatoid arthritis | Q37324840 |
| | Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment | Q37377989 |
| | Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab. | Q37554225 |
| | Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. | Q37603380 |
| | Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy | Q37722443 |
| | The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review | Q38237315 |
| | The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy | Q38281473 |
| | IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future | Q38343052 |
| | Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases | Q38635412 |
| | Novel Immunotherapeutic Avenues for Rheumatoid Arthritis | Q38732765 |
| | Immuno-PET Imaging of Engineered Human T Cells in Tumors | Q38761080 |
| | Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy? | Q38957340 |
| | Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases | Q38972531 |
| | Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis | Q38977479 |
| | Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. | Q38991972 |
| P304 | page(s) | 1536012117712638 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Molecular imaging : official journal of the Society for Molecular Imaging | Q26841928 |
| P1476 | title | In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis | |
| P478 | volume | 16 | |